The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching ...

The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, ...

The FENYX is valveless and able to self-prime 10x-40x faster than a syringe pump, helping OEMs eliminate unnecessary fluidic components such as flushing pumps, prime pumps, selector valves, and tubing ...

MGI are celebrating the 10th anniversary of their proprietary DNBSEQ™ Technology and are reflecting on past accomplishments ...